Comparative in Vitro Myocardial Inotropic Effects and in Vivo Hemodynamic Effects of Forskolin and Isoproterenol in Young Lambs

ABSTRACT: Previous studies have shown a decreased responsiveness of young lambs to isoproterenol, a ß-adrenergic agonist, when compared to older lambs. To see if this decreased responsiveness of immature lambs is secondary to an abnormality of the ß-adrenergic receptor/ adenylate cyclase complex, we compared the effects of isoproterenol to forskolin, a direct activator of the catalytic subunit of adenylate cyclase. In isometrically contracting right ventricular trabeculae from five lambs (5-13 d old), the maximal developed tension with isoproterenol (875 ± 84 mg, mean ± SD) and forskolin (704 ± 189 mg) was similar. However, the median effective dose for isoproterenol (5.3 ± 3.4 x 10-7 M) was significantly less than the minimal median effective dose for forskolin (2.5 ± 1.3 x 10-6 M) indicating a lesser sensitivity to forskolin. In eight conscious resting lambs (4-13 d old) we measured the hemodynamic response to graded infusions of isoproterenol and forskolin. At maximal dosage, the increase in cardiac output was significantly greater with isoproterenol (+130%) than forskolin (+55%). Heart rate also increased more with isoproterenol than forskolin. These data show that direct stimulation of adenylate cyclase in young lambs does not provide better inotropic or chronotropic responses than ß-adrenergic stimulation with isoproterenol. This suggests that the decreased ß-adrenergic responsiveness in newborn lambs is secondary to abnormalities that exist beyond the level of the ß-adrenergic receptor/adenylate cyclase complex.

[1]  A. Rudolph,et al.  Regulation of Cardiac Output with Controlled Heart Rate in Newborn Lambs , 1988, Pediatric Research.

[2]  M. Artman,et al.  Inotropic responses change during postnatal maturation in rabbit. , 1988, The American journal of physiology.

[3]  M. Heymann,et al.  Developmental Changes in Myocardial Contractile Reserve in the Lamb , 1985, Pediatric Research.

[4]  M. Bristow,et al.  Pharmacology and inotropic potential of forskolin in the human heart. , 1984, The Journal of clinical investigation.

[5]  J. Daly Forskolin, adenylate cyclase, and cell physiology: an overview. , 1984, Advances in cyclic nucleotide and protein phosphorylation research.

[6]  M. Heymann,et al.  Recovery of Cardiovascular Function in Newborn Lambs after Thoracotomy , 1982, Pediatric Research.

[7]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[8]  L. Cornett,et al.  Identification of β-Adrenergic Receptors Using [3H]Dihydroalprenolol in Fetal Sheep Heart: Direct Evidence of Qualitative Similarity to the Receptors in Adult Sheep Heart , 1981, Pediatric Research.

[9]  S. Vatner,et al.  Cellular mechanisms of impaired adrenergic responsiveness in neonatal dogs. , 1981, The Journal of clinical investigation.

[10]  H. Metzger,et al.  The positive inotropic-acting forskolin, a potent adenylate cyclase activator. , 1981, Arzneimittel-Forschung.

[11]  D. Rodbard,et al.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. , 1978, The American journal of physiology.

[12]  H. S. Klopfenstein,et al.  Postnatal Changes in the Circulation and Responses to Volume Loading in Sheep , 1978, Circulation research.

[13]  E. Lindner,et al.  Positive inotropic and blood pressure lowering activity of a diterpene derivative isolated from Coleus forskohli: Forskolin. , 1978, Arzneimittel-Forschung.

[14]  E. Johnson,et al.  The force of contraction of isolated papillary muscle: a study of the interaction of its determining factors. , 1977, Journal of molecular and cellular cardiology.

[15]  Edward A. Johnson,et al.  Force‐Frequency Relationship: A Basis for a New Index of Cardiac Contractility? , 1973, Circulation research.

[16]  W. Friedman,et al.  The intrinsic physiologic properties of the developing heart. , 1972, Progress in cardiovascular diseases.